Posted inClinical Updates Gastroenterology Radiology
Advances in MRI Biomarkers for Risk Stratification and Treatment Monitoring in Metabolic Dysfunction-Associated Steatotic Liver Disease
MRI-based biomarkers offer non-invasive, precise tools for diagnosing, risk stratifying, and monitoring treatment response in MASLD, potentially transforming patient management and clinical trial endpoints.